# FDA recall D-0018-2021

> **Direct Rx** · Class II · drug recall initiated 2019-04-30.

## Product

Losartan Potassium 100 mg, 30 Tabs bottles, Rx only,  Packaged and Distributed By: Direct Rx Dawsonville, GA 30534  NDC 61919-952-30

## Reason for recall

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level per manufacturer

## Distribution

GA

## Key facts

- **Recall number:** D-0018-2021
- **Recalling firm:** Direct Rx
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-04-30
- **Report date:** 2020-10-14
- **Termination date:** 2020-12-04

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Dawsonville, GA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0018-2021

## Citation

> AI Analytics. FDA recall D-0018-2021. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-0018-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*